Skip to main content
Home
 Terumo Group
Contact us
  
  • Products

      Products

    • Specialties
      • Interventional Cardiology
      • Interventional Oncology
      • Peripheral Intervention
    • Solutions
      • TRI - Transradial Intervention
      • R.A.V.I. - Radial Access for Visceral Intervention
    • All Products
  • Featured Topics

      Featured Topics

    • Ultimaster
    • Radial Edge
      • Distal Radial Access
    • TLA - Therapeutic Lesion Access
    • R.A.V.I. - Radial Access for Visceral Intervention
    • CCR
  • Clinical Evidence
  • Video Library
  • Education & Training
  • About Us

      About Us

    • TIS History
    • Who We Are
    • TIS Global Network
    • Company Profile
  • News & Events

      News & Events

    • News
    • Events
 Terumo Group
Contact us
  
  1. Home
  2. Featured Topics
  3. Radial Edge
  4. TRI 30th
To see the information that are approved in your region, please choose the relevant country or region below.
openclose
To see the information that are approved in your region, please choose the relevant country or region below.
openclose
Please be aware that this website is developed, controlled, and operated as an educational and informational site for Healthcare Professionals and in no event directed to the general public. Also please be aware that a reference to a product or service on this website does not imply that such product or service is or will be available in your country or region of the world where it may be subject to different regulations and conditions of use. You should always rely on product information especially created for your country. If necessary, please contact your local Terumo affiliate to obtain the appropriate product information for your country.
Your use of this Website is governed by the “Terms of Use” and the “Privacy Policy”, and you are strongly advised to read the Terms of Use and the Privacy Policy carefully before any further use of the Website. If you cannot accept the Terms of Use and the Privacy Policy, please exit this Website.
Note: This Website is not intended to be reviewed by residents of following countries/area. If you are a resident of any of the following countries/area, please click the relevant link and jump to the relevant website.
United States
Canada
Europe, Middle East and Africa
Brazil
Mexico
Chile
Colombia
LATAM (Others)
Australia & New Zealand
Japan
China
Accept Decline
featured_radial_tri30th_category_top_pc_2486x640.png
home_carousel_wide_tri30th_sp_750x600.png

TRI 30th

For 30 years, we have been supporting the progress of transradial intervention (TRI) and remain fully committed to working with physicians and patients to improve quality of life further.
TRI 30th Anniversary

The year 2022 marks the 30th anniversary since Dr. F. Kiemeneij performed the first transradial intervention (August 1992).

In celebration of this milestone, Terumo Interventional Systems features the history of the transradial approach, which has evolved together with our customers. We continue to advance a radial first approach as our commitment to improving the quality of life of our patients.

Featured Contents
TRI30th Newsletter Vol3 -  Latest Evidence and Guidelines for Radial Access

TRI30th Newsletter Vol4

Download newsletter
TRI30th Newsletter Vol3 - Global Symposium “30 Years of Transradial Access”

TRI30th Newsletter Vol3

Download newsletter
Distal Radial Access

Distal Radial Access

Go to website
Symposium & Events
featured_radial_tri30th_symposium_1280x1512.png

30 Years of Transradial Access:Pushing the boundaries in cardiology & beyond

 

For 30 years, Terumo Interventional Systems has focused on bringing radial access to the forefront of clinical practice.Our radial access product portfolio, clinical research, and collaborative educational programs have helped thousands of healthcare providers transform coronary care. Looking to the future, we remain fully committed to improving patients‘ quality of life by expanding radial access as the first choice for interventional procedures.

Watch the symposium
TRI x TIS History
  •  
 

1992

First Trans-radial Intervension

First trans-radial angiography/intervention in cardiology

history_1

Dr. Campeau (Canada, 1989)
Dr. Kiemeneij (The Netherlands, 1992)
Dr. Wu (Taiwan, 1993)
Dr. Saito (Japan, 1995)

2000

Product Launch

RADIFOCUS Introducer II M coat

history_2

RADIFOCUS Optitorque
TR Band

history_3

Trans-radial procedures

First trans-radial procedure in various fields

Neuro angioplasty (2000)
Renal stent (2001)
TACE (2002)
Neuro coil (2004)
Iliac stent (2005)

Expansion of Trans-radial procedures in the Europe Union

First PCR Live transmission by Dr. Saito
Massy TRI Course (France)

Publication

1st clinical study on Radifocus™ Introducer II Mcoat™ & the benefits of hydrophilic coating on TRI
Saito S. et al. Catheter Cardiovasc Interv 2002;56:328-32
Usefulness of hydrophilic coating on arterial sheath introducer in transradial coronary intervention - Saito - 2002 - Catheterization and Cardiovascular Interventions - Wiley Online Library

Clinical study on Radifocus™ Introducer II Mcoat™ & its benefits on patient discomfort following TRI
Kiemeneij F. et al. Catheter Cardiovasc Interv 2003;59:161-164
Hydrophilic coating aids radial sheath withdrawal and reduces patient discomfort following transradial coronary intervention: A randomized double‐blind comparison of coated and uncoated sheaths - Kiemeneij - 2003 - Catheterization and Cardiovascular Interventions - Wiley Online Library

2005

Product Launch

history_4

Heartrail II Guiding Catheter Ikari Curve
1.5 mm J-TIP Radifocus™ Guide Wire M / Baby J

history_5

1.5 mm J-TIP Radifocus™ Guide Wire M

Terumo Activity

China, Korea, Japan friendship TRI seminar was held

history_6

Brazil-Japan 100 years anniversary TRI seminar was held

history_7history_8

Training tools and simulators were developed

history_9

Trans-radial procedures

Expansion of trans-radial procedures in the United States, Asia, and Latin America

Publication

1st clinical study on Optitorque™'s universal shape TIGER II & its benefits for transradial angiography
Kim S-M et al. Int J Cardiovasc Imaging 2006;22:295-303
Novel diagnostic catheter specifically designed for both coronary arteries via the right transradial approach | SpringerLink

MORTAL Study demonstrates a reduction in mortality and transfusion rate with transradial access (PCI all-comers)
Chase AJ et al. Heart 2008;94:1019–25
Association of the arterial access site at angioplasty with transfusion and mortality: the M.O.R.T.A.L study (Mortality benefit Of Reduced Transfusion after percutaneous coronary intervention via the Arm or Leg) | Heart (bmj.com)

2010

Product Launch

history_10

Glidesheath Slender

history_11

Trans-radial procedures

Trans-radial intervention training for physicians in Latin America conducted through public-private partnership to contribute to improved patient quality of life and reduced healthcare expenditures.

ESC/EACTS 2014 guidelines: Class IIa A recommendation for patients with STEMI ACS -
Kolh P et al. Eur J Cardiothorac Surg 2014;46:517–92

PCI consensus document recommends aiming for the highest possible transradial rate for optimal outcomes
Rao S.V. et al. Catheter Cardiovasc Interv. 2014;83:228-36

Publication

1st clinical study on 6Fr Glidesheath Slender™ & its use for transradial coronary angiography and PCI
Aminian A. et al. Catheter Cardiovasc Interv 2014;84:436-442

2015

Trans-radial procedures

ESC 2015 Guidelines: Class 1 A recommendation for patients with non-STEMI -
Roffi M et al. Eur Heart J 2016;37:267–315.

ESC/EACTS 2018 Guidelines: Class 1 A recommendation for patients with STEMI ACS
Ibanez B et al. Eur Heart J 2018;39:119–7

ESC/EACTS 2018 Guidelines: Class 1 A recommendation
Neumann FJ et al. Eur Heart J 2019;40:87–16

Radial Access for Visceral Intervention (R.A.V.I)

Radial to Peripheral (R2P)

Distal radial approach

ESC 2019 guidelines: Class I B recommendation in elderly patients
Knuuti J et al. Eur Heart J 2020;41:407–77

International Consensus Paper on Best Practices for the pr ion of radial artery occlusion
Bernat I et al. J Am Coll Cardiol Interv 2019;12:2235–46.

Terumo Activity

Partnered with Euro PCR and conducted training.

Publication

The MATRIX Access trial demonstrates clinically relevant reduction in all-cause mortality with transradial access in patients with STEMI or non-STEMI ACS
Valgimigli M et al. Lancet 2015;385:2465–76

1st clinical study on 5Fr Glidesheath Slender™ & its use for transradial coronary angiography and PCI
Yoshimachi F. et al. Cardiovasc Interv and Ther 2016;31:38-41

RAP and BEAT trial compares 6Fr Glidesheath Slender™ with a standard 5 Fr sheath for transradial coronary angiography and PCI
Aminian A. et al. EuroIntervention. 2017;13:e549-e556.

CRASOC I, II, and III studies featuring with TR Band™ demonstrates the benefits of a gentle and short hemostasis for transradial coronary angiography and PCI
Dangoisse V. et al Am J Cardiol. 2017;120:374-379

1st clinical study on 7Fr Glidesheath Slender™ & its use for complex transradial PCI
Aminian A. et al. Catheter Cardiovasc Interv 2017;89:1014-1020

RAP and BEAT trial substudy featuring with TR Band™ demonstrates the benefits of short hemostasis time on radial artery patency
Aminian A. et al Catheter Cardiovasc Interv. 2018 ;92:844-851

Clinical trial on Optitorque™'s universal shape TIGER II & its benefits over conventional two-catheter strategy
Xanthopoulou I et al. EuroIntervention 2018;13:1950-1958

Clinical study featuring Optitorque™'s universal shape TIGER I demonstrates a positive impact on coronary catheterization performance and economic costs
Costa-Mateu J et al. Arq Bras Cardiol 2019;113:960-968

Clinical study featuring 7 Fr Glidesheath Slender™ supports its uses for left distal transradial approach & CTO intervention
Gasparini G.L. et al. EuroIntervention. 2019;15:126-128

2020

Product Launch

RADIFOCUS Glidecath R.A.V.I. MG1/MG2 Shape

Trans-radial procedures

ACC/AHA/SCAI Decision to Designate Radial Access Class 1, Level of Evidence A
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines | Journal of the American College of Cardiology (jacc.org)

Publication

COLOR Trial featuring 7Fr Glidesheath Slender™ demonstrates that TRA is superior to TFA in complex large bore PCI
Meijers T.A. et al. JACC Cardiovasc Interv.2021;14:1293-1303

1st clinical study on Heartrail II's Ikari left curve & its benefits door-to-balloon time for PCI STEMI patients
Lee K.H. et al. Catheter Cardiovasc Interv. 2021 May 31. Online ahead of print

DISCO RADIAL trial featuring Glidesheath Slender™ designed to investigate the benefits of dTRA over cTRA on RAO rates at discharge
Terumo Press Release 21 January 2020. Available at: https://www.terumo.com/pressrelease/detail/20200121/514/; Glidesheath Slender™ product
information https://www.terumois.com/products/access/glidesheath-slender.html; all accessed May 2020

pattern01.png

Newsletter
 
featured_radial_tri30th_newsletter_410x200.png

TRI 30th Anniversary Newsletter

Radial approach topics are regularly available and include the history, clinical outcomes, benefits, dedicated devices, guidelines, and other topics.

Vol.4 Latest Evidence and Guidelines for Radial Access
Vol.3 30 Years of Transradial Access
Vol.2 Same-Day Discharge
Vol.1 TRI History
Product Information
featured_radial_tri30th_product_glidesheath_slender_980x320
featured_radial_tri30th_product_radifocus_guide_wire_m_980x320
featured_radial_tri30th_product_radifocus_optitorque_980x320
featured_radial_tri30th_product_heartrail_II_980x320
featured_radial_tri30th_product_tr_band_980x320
featured_radial_tri30th_product_ravi_980x320
Educational Contents
 
featured_radial_tri30th_educational_contents_sheath_insertion
Sheath Insertion
The use of a slender sheath is effective in reducing the risk of arterial spasms and radial occlusion. Glidesheath SlenderTM ensures smooth insertion and removal during the transradial procedures.1
Read more
 
featured_radial_tri30th_educational_contents_catheter_manipulation
Catheter Manipulation
This section provides instructions on how to manipulate the bilateral angiographic catheter to engage both coronary arteries efficiently. Tips are provided on ways to manage a complex anatomy.
Read more
 
featured_radial_tri30th_educational_contents_hemostasis
Hemostasis
The TR Band and patent hemostasis can help to minimize radial artery risks, such as radial artery occlusion (RAO).2
Read more

Reference

 
  1. Kiemeneij F, et al, Catheter Cardiovasc Interv. 2003; 59 (2): 161-164
  2. Rathore S. et al., 2010. A Randomized Comparison of TR Band and Radistop Hemostatic Compression Devices Afer Trans-radial Coronary Intervention. Catheterization and Cardiovascular Interventions, 76 (5), pp.660–667.
How can we assist you?

At Terumo Interventional Systems, we don’t just deliver quality medical products – we offer the necessary resources and support to help you use them to their full potential. Contact us today for any assistance you may need.

Contact us
contact_us_pc_2486x860.png
Home
 
Top
  • Products
    • Specialties
      • Interventional Cardiology
      • Interventional Oncology
      • Peripheral Intervention
    • Solutions
      • TRI - Transradial Intervention
      • R.A.V.I. - Radial Access for Visceral Intervention
    • All Products
  • Featured Topics
    • Ultimaster
    • Radial Edge
      • Distal Radial Access
    • TLA - Therapeutic Lesion Access
    • R.A.V.I. - Radial Access for Visceral Intervention
    • CCR
  • Clinical Evidence
  • Video Library
  • Education & Training
  • About Us
    • TIS History
    • Who We Are
    • TIS Global Network
    • Company Profile
  • News & Events
    • News
    • Events
 Newsletter
 
  1. Home
  2. Featured Topics
  3. Radial Edge
  4. TRI 30th
  • Terms of Use
  • Privacy Policy
  • Cookie Settings
  • Cookie Policy
  • Social Media Policy
  • Site Map
  • Contact Us

Copyright©️Terumo Corporation, All Rights Reserved. All brand names are trademarks or registered trademarks owned by TERUMO CORPORATION, its affiliates, or unrelated third parties.